Superseded - Composition of the Emergency Task Force (ETF) for preparedness
Submitted by Anonymous (not verified) on 7 August 2025 - 15:26
Superseded - Composition of the Emergency Task Force (ETF) for preparedness
Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 9, Status: Authorised
Submitted by Anonymous (not verified) on 7 August 2025 - 15:00
Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Brintellix, vortioxetine, Date of authorisation: 18/12/2013, Revision: 25, Status: Authorised
Submitted by Anonymous (not verified) on 7 August 2025 - 14:44
Human medicines European public assessment report (EPAR): Brintellix, vortioxetine, Date of authorisation: 18/12/2013, Revision: 25, Status: Authorised
Applications for new human medicines under evaluation: August 2025
Submitted by Anonymous (not verified) on 7 August 2025 - 13:41
Applications for new human medicines under evaluation: August 2025
Vaccine Monitoring Platform
Submitted by Anonymous (not verified) on 7 August 2025 - 12:47
Vaccine Monitoring Platform
Vaccine Monitoring Platform: List of EMA-funded studies
Submitted by Anonymous (not verified) on 7 August 2025 - 12:45
Vaccine Monitoring Platform: List of EMA-funded studies
Medicine shortage communication (MSC): Zypadhera (olanzapine pamoate monohydrate powder and solvent for prolonged release suspension for injection)
Submitted by Anonymous (not verified) on 7 August 2025 - 10:12
Medicine shortage communication (MSC): Zypadhera (olanzapine pamoate monohydrate powder and solvent for prolonged release suspension for injection)
Agenda - Multi-stakeholder workshop on tailored clinical approach for biosimilars
Submitted by Anonymous (not verified) on 7 August 2025 - 10:08
Agenda - Multi-stakeholder workshop on tailored clinical approach for biosimilars
Ketoprofen: European public maximum-residue-limit assessment report (EPMAR) - CVMP
Submitted by Anonymous (not verified) on 6 August 2025 - 15:15
Ketoprofen: European public maximum-residue-limit assessment report (EPMAR) - CVMP
Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 33, Status: Authorised
Submitted by Anonymous (not verified) on 6 August 2025 - 14:54
Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 33, Status: Authorised